The global bladder cancer market is growing at a significant CAGR during the forecast period. Bladder cancer is one of the most common cancer types. This cancer occurs more frequently in men rather than women in addition older adults are more prone to the disease. Most bladder cancer diagnosed start at an early stage when the cancer is highly treatable. However, despite being early-stage treatable cancer can recur after treatment owing to which bladder cancer patients usually need to follow up tests even after the disease is cured. The exact causes of this cancer are still unknown. However, some speculated risk factors are continuous exposure to radiation, tobacco consumption, chronic bladder infection, and excessive smoking.

Request a free sample of our report on Global Bladder Cancer Market: https://www.omrglobal.com/request-sample/bladder-cancer-market

Factors Driving the Global Bladder Cancer Market

Increased adoption of immunotherapy treatments
The rise in bladder cancer incidents
Advancement in healthcare technologies
Growing research & development of cancer therapies

A full report of Global Bladder Cancer Market is available at: https://www.omrglobal.com/industry-reports/bladder-cancer-market

The predominant factors driving the growth of the bladder cancer market is the rise in bladder cancer cases across the globe. Bladder cancer is the ninth common cancer type globally. Symptoms of bladder cancer include dysuria, hematuria, frequent urinary tract infections and increased urinary frequency. Urothelial carcinoma commonly known as transitional cell carcinoma constitutes more than 90% of bladder cancer. Moreover, the boost in immunotherapy adoption is significantly contributing to the growth of the market. Immunotherapy is a treatment for cancer that propels the natural defense of the body to fight with cancer, the treatment uses laboratory-made monoclonal antibodies.

Another major factor that is driving the growth of the bladder cancer market is a boost in R&D and the launch of new therapies. Introduction of new pipeline agents such as CG-0070, Vicinium, and Cyramza is expected to propel the market growth during the forecast period. Further, government initiatives, rise in aging population, and the upsurge in awareness about bladder diseases are assisting in the market growth. However, increased use of generic drugs, asymptomatic nature of the disease, boost in drug patent expiration and high cost of cancer treatment therapies are expected to hamper the growth of the market. Moreover, factors such as the rising influence of targeted biologics and acceptance of effective diagnostic tools are anticipated to drive the market.

The key players dominating the global bladder cancer market include AstraZeneca Plc, Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Novartis International AG, Pfizer Inc, Sanofi S.A., and Merck & Co. Inc. Some of the strategies that are majorly being adopted include new products and services offering, expansion, mergers & acquisitions among others. For instance, in March 2019, AstraZeneca Plc joined hands with Daiichi Sankyo, the companies agreed to produce trastuzumab deruxtecan (DS-8201) which is an antibody-drug conjugate (ADC) and produce potential new targeted drugs for cancer treatment as well.

Global Bladder Cancer Market- Segment

By Cancer Type

Transitional Cell Bladder Cancer/ Urothelial Carcinoma
Squamous Cell Bladder Cancer
Adenocarcenoma
Other Rare Types ( Sarcomas, Carcinoma in Situ)

By Diagnosis Method

Cystoscopy
Biopsy
Urinalysis
Urine Cytology
Intervenous Pylogram
Other

By Therapy

Chemotherapy
Immunotherapy
Radiation Therapy
Surgery
Others

Global Bladder Cancer Market- Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Visit here to know more about Global Bladder Cancer Market Size.

About Orion Market Research

Orion Market Research (OMR) is an Indian market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Reports

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +1 646-755-7667, +91 780-304-0404